Skip to main content

Table 3 Association between each risk score as continuous variables and thromboembolic event in both cohorts

From: Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation

 

Non anticoagulated cohort

Anticoagulated cohort

HR (95 % CI)

HR (95 % CI)

CHA2DS2-VASc

1.58 (1.01–2.46)

1.49 (1.13–1.97)

p = 0.044

p = 0.005

R2CHADS2

1.23 (0.86–1.77)

1.41 (1.13–1.77)

p = 0.25

p = 0.03

ATRIA

1.20 (0.93–1.56)

1.37 (1.12–1.66)

p = 0.17

p = 0.002

  1. ATRIA the anticoagulation and risk factors in atrial fibrillation score, CHA2DS2-VASc congestive heart failure, hypertension, age ≥75, diabetes mellitus, prior stroke or transient ischemic attack, vascular disease, age 65–74, female, CI confidence interval, HR hazard ratio, NVAF nonvalvular atrial fibrillation, p; p value, R 2 CHADS 2 renal dysfunction, congestive heart failure, hypertension, age ≥75, diabetes mellitus, prior stroke or transient ischemic attack
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us